Cinctive Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Cinctive Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$4.42M	–	390
2025 Q4	$4.42M	Buy	20,000 +7,934	+66%	+$1.28M	0.24%	120
2025 Q3	$1.16M	Buy	+12,066	New	+$770K	0.06%	293

Cinctive Capital Management's CDTX Position: Q1 2026 in Review

Cinctive Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 20,000 shares — an estimated $4.42M sold.

Cinctive Capital Management first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $4.42M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Cinctive Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Cinctive Capital Management sold 20,000 Cidara Therapeutics shares in Q1 2026, an estimated $4.42M.
Cinctive Capital Management first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Cinctive Capital Management's Cidara Therapeutics position peaked at $4.42M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.